Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2837-2839
Published online before print September 28, 2006, doi: 10.1161/01.STR.0000245085.58807.ad
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v38,p1117)
Right arrow All Versions of this Article:
37/11/2837    most recent
01.STR.0000245085.58807.adv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delgado, P.
Right arrow Articles by Montaner, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delgado, P.
Right arrow Articles by Montaner, J.
Related Collections
Right arrow Acute Cerebral Hemorrhage

(Stroke. 2006;37:2837.)
© 2006 American Heart Association, Inc.


Short Communication

Plasma S100B Level After Acute Spontaneous Intracerebral Hemorrhage

Pilar Delgado, MD; Jose Alvarez Sabin, MD, PhD; Esteban Santamarina, MD; Carlos A. Molina, MD, PhD; Manuel Quintana; Anna Rosell, PhD Joan Montaner, MD, PhD

From the Neurovascular Research Laboratory and the Stroke Unit, Departament de Medicina, Universitat Autònoma de Barcelona, Hospital General Vall d’Hebron, Barcelona, Spain.

Correspondence to Dr Pilar Delgado Martinez, Neurovascular Research Laboratory, Institut de Recerca, Hospital General Vall d’Hebron, Passeig Vall d’Hebrón 119-129, 08035 Barcelona, Spain. E-mail 35070pdm{at}comb.es

Background and Purpose— We sought to determine plasma S100B level after acute (<24 hours) spontaneous intracerebral hemorrhage (ICH) and to study its relation with neurological outcome.

Methods— We determined S100B concentration on plasma samples from 78 ICH patients on admission. Clinical (Glasgow Coma Scale and National Institutes of Health Stroke Scale [NIHSS] scores) and radiological information (ICH and perihematomal edema volumes) were collected at baseline and follow-up visits. Early neurological deterioration, defined as the increase of ≥4 points in the NIHSS score at 48 hours, and unfavorable outcome (modified Rankin Scale >2) at 3 months were also recorded.

Results— The median S100B level was higher than our laboratory reference values for healthy controls (103.6 versus 48.5 pg/mL; P<0.001) and a positive correlation was observed between S100B level and baseline ICH volume (r=0.45; P<0.0001). The median S100B level was higher in patients who deteriorated early (256.8 versus 89.7 pg/mL; P=0.001) and also in patients with an unfavorable outcome (136 versus 75.9 pg/mL; P=0.003). Multivariate analysis showed baseline ICH volume as the best predictor for both early neurological deterioration (odds ratio 15; 95% CI, 2.9 to 76.3) and unfavorable outcome at 3 months (odds ratio 17; 95% CI, 2.0 to 142).

Conclusion— Increased S100B level is found after acute spontaneous ICH, in association with a worse early and late evolution, and closely related to initial hematoma volume.


Key Words: biomarkers • intracerebral hemorrhages • S100B • stroke